The microtomes market is projected to reach USD 585.2 million by 2027 from USD 425.4 million in 2022, at a CAGR of 6.6%. Some of the key factors driving the growth of this market include the high prevalence of cancer, growing demand for digital pathology, and the increasing healthcare expenditure. In addition, the growing focus on personalized medicine and the untapped growth potential of emerging economies are expected to offer growth opportunities for players operating in the microtomes market. However, a lack of skilled professionals to operate microtomes is a key challenge for the growth of this market.
Based on end user the market is classified into hospital laboratories, clinical laboratories, and other end-users. The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals.
Microtome instruments in the product segment to witness the highest shares during the forecast period
Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market.
In this report, the microtome market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising disposable income of the middle-class population, infrastructural developments, and the rising penetration of diagnostic technologies in Asian countries such as India and China in addition, the rising incidence of cancer and the growing focus of global medical device companies on expanding their presence in emerging Asia Pacific countries are some of the key factors.
This report studies the microtome market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total microtome market. The report forecasts the revenue of the market segments with respect to five major regions.
Based on end user the market is classified into hospital laboratories, clinical laboratories, and other end-users. The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals.
Microtome instruments in the product segment to witness the highest shares during the forecast period
Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market.Asia Pacific is estimated to register the highest CAGR during the forecast period
In this report, the microtome market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising disposable income of the middle-class population, infrastructural developments, and the rising penetration of diagnostic technologies in Asian countries such as India and China in addition, the rising incidence of cancer and the growing focus of global medical device companies on expanding their presence in emerging Asia Pacific countries are some of the key factors.
Research Coverage
This report studies the microtome market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total microtome market. The report forecasts the revenue of the market segments with respect to five major regions.
List of Companies Profiled
- Danaher Corporation (US)
- Boeckeler Instruments, Inc. (US)
- SM Scientific Instruments Pvt. Ltd. (India)
- PHC holdings corporation (Japan)
- Cardinal Health (US)
- Bright Instruments (UK)
- Sakura Finetek USA, Inc. (US)
- Jinhua Yidi Medical Equipment Co. Ltd. (China)
- Ted Pella, Inc. (US)
- Medimeas (India)
- SLEE medical GmbH (Germany)
- Histo-Line Laboratories (Italy)
- microTec Laborgeräte GmbH (Germany)
- MEDITE Medical GmbH (Germany)
- Campden Instruments (UK)
- Lupetec (Brazil)
- AGD BIOMEDICALS Pvt. Ltd. (India)
- Lafayette Instrument Company (US)
- MILESTONE MEDICAL (US)
- Diapath S.p.A. (Italy)
- RWD Life Science Co. Ltd. (China)
- LABOID INTERNATIONAL (India)
- Shenzhen Dakewei Biotechnology Co. Ltd. (China)
- Amos scientific Pty. Ltd. (Australia)
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
- By Designation: C-level (30%), Director-level (34%), and Others (36%)
- By Region: North America (40%), Europe (28%), Asia-Pacific (20%), and Rest of the World (12%)
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on microtome products offered by the top 25 players in the microtome market. The report analyzes the microtome market by product, and region.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
- Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the microtome market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the microtome market
Table of Contents
1 Introduction
2 Research Methodology
4 Premium Insights
5 Market Overview
6 Microtomes Market, By Product
7 Microtomes Market, By Application
8 Microtomes Market, By Technology
9 Microtomes Market, By End User
10 Microtomes Market, By Region
11 Competitive Landscape
12 Company Profiles
13 Appendix
List of Tables
List of Figures
Companies Mentioned
- AGD BIOMEDICALS Pvt. Ltd. (India)
- Amos scientific Pty. Ltd. (Australia)
- Boeckeler Instruments, Inc. (US)
- Bright Instruments (UK)
- Campden Instruments (UK)
- Cardinal Health (US)
- Danaher Corporation (US)
- Diapath S.p.A. (Italy)
- Histo-Line Laboratories (Italy)
- Jinhua Yidi Medical Equipment Co. Ltd. (China)
- LABOID INTERNATIONAL (India)
- Lafayette Instrument Company (US)
- Lupetec (Brazil)
- Medimeas (India)
- MEDITE Medical GmbH (Germany)
- microTec Laborgeräte GmbH (Germany)
- MILESTONE MEDICAL (US)
- PHC holdings corporation (Japan)
- RWD Life Science Co. Ltd. (China)
- Sakura Finetek USA, Inc. (US)
- Shenzhen Dakewei Biotechnology Co. Ltd. (China)
- SLEE medical GmbH (Germany)
- SM Scientific Instruments Pvt. Ltd. (India)
- Ted Pella, Inc. (US)
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 211 |
| Published | May 2022 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 425 Million |
| Forecasted Market Value ( USD | $ 585 Million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
